Catheter-directed thrombolysis is gaining momentum for submassive pulmonary embolism due to theoretically improved safety, though its appropriate use remains actively debated.
Answers are grounded in this paper and cite their sources.
Catheter-directed thrombolysis may offer safer options in submassive PE; leaves open optimal use pending randomized trials.
Submassive pulmonary embolism (PE) remains a vexing entity, and the appropriate use of thrombolytic therapy for this subgroup continues to be actively debated. Catheter-directed thrombolysis has shown efficacy for submassive PE and is gaining momentum because of theoretically improved safety. This review poses and responds to four questions that explore the complex issues surrounding optimal therapy of submassive PE.
No takes yet. Share an insight, caveat, or question.
Sista et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: